ITT
CBT
ADNT

Douglas G. Delgrosso

Known title: DirectorCIK: 0001193775

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

ITT Announces Q3 2026 Earnings Release; Conglomerates Lag Behind. ITT has set a date for its third‑quarter 2026 earnings release and conference call. Analysts are comparing ITT to MITSY to assess value, while a recent Yahoo piece notes that conglomerate stocks are trailing ITT this year. The company’s focus on expanding its flow business could strengthen its core operations.

this person other insiders at ITT

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 16, 2026

Cabot Corp to Report Q4 FY2026 Results. Cabot Corporation will release its fourth‑quarter and full‑year 2026 operating results on Friday. The announcement follows a period of steady performance and may influence the stock’s near‑term movement. A recent article highlighted the company’s dividend yield of 2.06% and earnings guidance as key factors for investors. The stock is currently trading near its 52‑week low and close to a support level of $74.80.

this person other insiders at CBT

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 13, 2026

Adient Q4 Earnings Set for Nov. 4 as Analysts Trim Targets. Adient will report fourth-quarter and full-year fiscal 2026 results on November 4, 2026. Ahead of this announcement, Barclays and UBS both lowered their price targets to $22 and $23, respectively, while maintaining their ratings. Recent commentary also highlights strong backlog growth driven by onshoring initiatives and new customer wins.

this person other insiders at ADNT

Transaction History

ITT▲ Buy$0
CBT▲ Buy$0
ITT▲ Buy$0
CBT▲ Buy$0
CBT▲ Buy$0
ADNT▼ Sell$664K
ADNT▼ Sell$383K
ADNT▼ Sell$490K
ADNT▲ Buy—
ADNT▲ Buy—
ADNT▼ Sell$5.8M
ADNT▼ Sell$134K
ADNT▼ Sell$810K
ADNT▼ Sell$9K
CBT▲ Buy$0
ADNT▼ Sell$2.0M
ADNT▼ Sell$777K
ADNT▼ Sell$1.1M
ADNT▼ Sell$4.2M
ADNT▲ Buy$0
ADNT▲ Buy$0
ADNT▲ Buy$0
ADNT▼ Sell$71K
CBT▲ Buy$0
ADNT▼ Sell$905K
ADNT▲ Buy$0
ADNT▲ Buy$0
ADNT▼ Sell$2.0M
ADNT▲ Buy—
ADNT▼ Sell$2.5M
ADNT▼ Sell$356K

We use analytics to understand how market-wall is used. No personal data is sold.